Top 20 Vaccine Companies In-depth Analysis 2020: Sanofi, Pfizer, GlaxoSmithKline (GSK), Merck & Co., AstraZeneca, Emergent BioSolutions, Mitsubishi Tanabe Pharma, Seqirus (CSL Limited), Other Companies
“Top 20 Vaccine Companies In-depth Analysis 2020: Sanofi, Pfizer, GlaxoSmithKline (GSK), Merck & Co., AstraZeneca, Emergent BioSolutions, Mitsubishi Tanabe Pharma, Seqirus (CSL Limited), Other Companies”
This report presents an in-depth assessment of the top 20 vaccine companies' market dynamics, opportunities, competitive landscape and discusses major trends.
The report offers the most up-to-date top 20 vaccine companies market data from 2015 to 2019. A comprehensive analysis has been done on market share and ranking with the percentage of all the leading 20 vaccine companies. The report also provides a detailed description of growth drivers and inhibitors of the vaccine market. Key trends in terms of collaboration and partnership deals, merger and acquisition, distribution, exclusive, and licensing agreements are analyzed with details.
The report concludes with the profiles of the top 20 vaccine companies in the vaccines market. The key players are evaluated on various parameters such as business overview, vaccines portfolio, promising vaccines in the clinical development, vaccines market value analysis, and strategic development.
The Top 20 Leading Companies Dominating this Market for its Products, Services, and Continuous Product Developments are:
This report presents an in-depth assessment of the top 20 vaccine companies' market dynamics, opportunities, competitive landscape and discusses major trends.
The report offers the most up-to-date top 20 vaccine companies market data from 2015 to 2019. A comprehensive analysis has been done on market share and ranking with the percentage of all the leading 20 vaccine companies. The report also provides a detailed description of growth drivers and inhibitors of the vaccine market. Key trends in terms of collaboration and partnership deals, merger and acquisition, distribution, exclusive, and licensing agreements are analyzed with details.
The report concludes with the profiles of the top 20 vaccine companies in the vaccines market. The key players are evaluated on various parameters such as business overview, vaccines portfolio, promising vaccines in the clinical development, vaccines market value analysis, and strategic development.
The Top 20 Leading Companies Dominating this Market for its Products, Services, and Continuous Product Developments are:
- Sanofi Pasteur
- GlaxoSmithKline (GSK)
- Merck & Co., Inc.
- Pfizer
- AstraZeneca
- Mitsubishi Tanabe Pharma
- Emergent BioSolutions
- Astellas Pharma Inc.
- Valneva
- Seqirus(CSL Limited)
- Bavarian Nordic
- Sinovac
- Panacea Biotec
- Dynavax Technologies Corporation
- Bharat Biotech
- Serum Institute of India
- Biological E. Limited
- Grifols
- Hualan Biological Engineering Inc
- Gamma Vaccines Pty Ltd
- The Total Market Value of the Top 20 Vaccine Companies
- Top 20 Vaccine Companies Market Share and Ranking in the Vaccines Market
- Investigates the Key Growth Drivers and Restraints of the Vaccines Market
- Provides Key Trends with Respect to Collaborations, Partnerships, Merger and Acquisitions, Distribution, Exclusive and Licensing Agreement
- In-depth Assessment of the Top 20 Vaccine Companies Along with the Analysis of their Current Vaccines Portfolios, Promising Vaccines in the Clinical Development, Market Value Analysis, and Strategic Development
- Who are the top 20 leading companies in the vaccine market?
- What is the top leading companies’ strategic development?
- Which company has the highest market share in the vaccine market?
- How many vaccines are in clinical development by the top leading companies?
- What is the vaccine market value of the top leading companies?
- How many vaccines available in the marketby the top leading companies?
- What are the major drivers of the vaccine market?
- What are the major inhibitors of the vaccine market?
- What are the major deals happenings in the vaccine market?
- What is the competitive landscape in the vaccine market?
1. EXECUTIVE SUMMARY
2. GLOBAL TOTAL MARKET VALUE OF THE TOP 20 VACCINE COMPANIES (2015 – 2019)
3. MARKET SHARE ANALYSIS OF THE TOP 20 VACCINE COMPANIES (%)
4. KEY MARKET DRIVERS AND INHIBITORS IN THE VACCINE MARKET
4.1 Key Market Drivers
4.2 Key Market Inhibitors
5. MAJOR DEALS AND AGREEMENT HAPPENINGS IN THE VACCINE MARKET
5.1 Merger & Acquisitions
5.2 Collaboration Deals
5.3 Licensing Agreement
5.4 Exclusive Agreement
5.5 Distribution Agreement
5.6 Partnership Deals
6. TOP 20 VACCINE COMPANIES IN THE VACCINE MARKET
6.1 Sanofi Pasteur
6.1.1 Business Overview
6.1.2 Vaccines Portfolio
6.1.3 Vaccines Market Value Analysis
6.1.4 Promising Vaccines in the Clinical Development
6.1.5 Recent Development
6.2 GlaxoSmithKline (GSK)
6.2.1 Business Overview
6.2.2 Vaccines Portfolio
6.2.3 Vaccines Market Value Analysis
6.2.4 Promising Vaccines in the Clinical Development
6.2.5 Recent Development
6.3 Merck & Co., Inc.
6.3.1 Business Overview
6.3.2 Vaccines Portfolio
6.3.3 Vaccines Market Value Analysis
6.3.4 Promising Vaccines in the Clinical Development
6.3.5 Recent Development
6.4 Pfizer
6.4.1 Business Overview
6.4.2 Vaccines Portfolio
6.4.3 Vaccines Market Value Analysis
6.4.4 Promising Vaccines in the Clinical Development
6.4.5 Recent Development
6.5 AstraZeneca
6.5.1 Business Overview
6.5.2 Vaccines Portfolio
6.5.3 Vaccines Market Value Analysis
6.5.4 Recent Development
6.6 Mitsubishi Tanabe Pharma
6.6.1 Business Overview
6.6.2 Vaccines Portfolio
6.6.3 Vaccines Market Value Analysis
6.6.4 Promising Vaccines in the Clinical Development
6.6.5 Recent Development
6.7 Emergent BioSolutions
6.7.1 Business Overview
6.7.2 Vaccines Portfolio
6.7.3 Vaccines Market Value Analysis
6.7.4 Promising Vaccines in the Clinical Development
6.7.5 Recent Development
6.8 Astlellas Pharma Inc
6.8.1 Business Overview
6.8.2 Vaccines Portfolio
6.8.3 Vaccines Market Value Analysis
6.8.4 Recent Development
6.9 Valneva
6.9.1 Business Overview
6.9.2 Vaccines Portfolio
6.9.3 Vaccines Market Value Analysis
6.9.4 Promising Vaccines in the Clinical Development
6.9.5 Recent Development
6.10 Seqirus (CSL Limited)
6.10.1 Business Overview
6.10.2 Vaccines Portfolio
6.10.3 Vaccines Market Value Analysis
6.10.4 Promising Vaccines in the Clinical Development
6.10.5 Recent Development
6.11 Bavarian Nordic
6.11.1 Business Overview
6.11.2 Vaccines Portfolio
6.11.3 Vaccines Market Value Analysis
6.11.4 Promising Vaccines in the Clinical Development
6.11.5 Recent Development
6.12 Sinovac
6.12.1 Business Overview
6.12.2 Vaccines Portfolio
6.12.3 Vaccines Market Value Analysis
6.12.4 Promising Vaccines in the Clinical Development
6.12.5 Recent Development
6.13 Panacea Biotec
6.13.1 Business Overview
6.13.2 Vaccines Portfolio
6.13.3 Vaccines Market Value Analysis
6.13.4 Promising Vaccines in the Clinical Development
6.13.5 Recent Development
6.14 Dynavax Technologies Corporation
6.14.1 Business Overview
6.14.2 Vaccines Portfolio
6.14.3 Vaccines Market Value Analysis
6.14.4 Promising Vaccines in the Clinical Development
6.14.5 Recent Development
6.15 Bharat Biotech
6.15.1 Business Overview
6.15.2 Vaccines Portfolio
6.15.3 Promising Vaccines in the Clinical Development
6.15.4 Recent Development
6.16 Serum Institute of India
6.16.1 Business Overview
6.16.2 Vaccines Portfolio
6.16.3 Promising Vaccines in Clinical Development
6.16.4 Recent Development
6.17 Biological E. Limited
6.17.1 Business Overview
6.17.2 Vaccines Portfolio
6.17.3 Promising Vaccines in the Clinical Development
6.17.4 Recent Development
6.18 Grifols
6.18.1 Business Overview
6.18.2 Vaccines Portfolio
6.18.3 Recent Development
6.19 Hualan Biological Engineering Inc
6.19.1 Business Overview
6.19.2 Influenza Vaccines Portfolio
6.19.3 Recent Development
6.20 Gamma Vaccines Pty Ltd
6.20.1 Business Overview
6.20.2 Influenza Vaccines Portfolio
6.20.3 Recent Development
2. GLOBAL TOTAL MARKET VALUE OF THE TOP 20 VACCINE COMPANIES (2015 – 2019)
3. MARKET SHARE ANALYSIS OF THE TOP 20 VACCINE COMPANIES (%)
4. KEY MARKET DRIVERS AND INHIBITORS IN THE VACCINE MARKET
4.1 Key Market Drivers
4.2 Key Market Inhibitors
5. MAJOR DEALS AND AGREEMENT HAPPENINGS IN THE VACCINE MARKET
5.1 Merger & Acquisitions
5.2 Collaboration Deals
5.3 Licensing Agreement
5.4 Exclusive Agreement
5.5 Distribution Agreement
5.6 Partnership Deals
6. TOP 20 VACCINE COMPANIES IN THE VACCINE MARKET
6.1 Sanofi Pasteur
6.1.1 Business Overview
6.1.2 Vaccines Portfolio
6.1.3 Vaccines Market Value Analysis
6.1.4 Promising Vaccines in the Clinical Development
6.1.5 Recent Development
6.2 GlaxoSmithKline (GSK)
6.2.1 Business Overview
6.2.2 Vaccines Portfolio
6.2.3 Vaccines Market Value Analysis
6.2.4 Promising Vaccines in the Clinical Development
6.2.5 Recent Development
6.3 Merck & Co., Inc.
6.3.1 Business Overview
6.3.2 Vaccines Portfolio
6.3.3 Vaccines Market Value Analysis
6.3.4 Promising Vaccines in the Clinical Development
6.3.5 Recent Development
6.4 Pfizer
6.4.1 Business Overview
6.4.2 Vaccines Portfolio
6.4.3 Vaccines Market Value Analysis
6.4.4 Promising Vaccines in the Clinical Development
6.4.5 Recent Development
6.5 AstraZeneca
6.5.1 Business Overview
6.5.2 Vaccines Portfolio
6.5.3 Vaccines Market Value Analysis
6.5.4 Recent Development
6.6 Mitsubishi Tanabe Pharma
6.6.1 Business Overview
6.6.2 Vaccines Portfolio
6.6.3 Vaccines Market Value Analysis
6.6.4 Promising Vaccines in the Clinical Development
6.6.5 Recent Development
6.7 Emergent BioSolutions
6.7.1 Business Overview
6.7.2 Vaccines Portfolio
6.7.3 Vaccines Market Value Analysis
6.7.4 Promising Vaccines in the Clinical Development
6.7.5 Recent Development
6.8 Astlellas Pharma Inc
6.8.1 Business Overview
6.8.2 Vaccines Portfolio
6.8.3 Vaccines Market Value Analysis
6.8.4 Recent Development
6.9 Valneva
6.9.1 Business Overview
6.9.2 Vaccines Portfolio
6.9.3 Vaccines Market Value Analysis
6.9.4 Promising Vaccines in the Clinical Development
6.9.5 Recent Development
6.10 Seqirus (CSL Limited)
6.10.1 Business Overview
6.10.2 Vaccines Portfolio
6.10.3 Vaccines Market Value Analysis
6.10.4 Promising Vaccines in the Clinical Development
6.10.5 Recent Development
6.11 Bavarian Nordic
6.11.1 Business Overview
6.11.2 Vaccines Portfolio
6.11.3 Vaccines Market Value Analysis
6.11.4 Promising Vaccines in the Clinical Development
6.11.5 Recent Development
6.12 Sinovac
6.12.1 Business Overview
6.12.2 Vaccines Portfolio
6.12.3 Vaccines Market Value Analysis
6.12.4 Promising Vaccines in the Clinical Development
6.12.5 Recent Development
6.13 Panacea Biotec
6.13.1 Business Overview
6.13.2 Vaccines Portfolio
6.13.3 Vaccines Market Value Analysis
6.13.4 Promising Vaccines in the Clinical Development
6.13.5 Recent Development
6.14 Dynavax Technologies Corporation
6.14.1 Business Overview
6.14.2 Vaccines Portfolio
6.14.3 Vaccines Market Value Analysis
6.14.4 Promising Vaccines in the Clinical Development
6.14.5 Recent Development
6.15 Bharat Biotech
6.15.1 Business Overview
6.15.2 Vaccines Portfolio
6.15.3 Promising Vaccines in the Clinical Development
6.15.4 Recent Development
6.16 Serum Institute of India
6.16.1 Business Overview
6.16.2 Vaccines Portfolio
6.16.3 Promising Vaccines in Clinical Development
6.16.4 Recent Development
6.17 Biological E. Limited
6.17.1 Business Overview
6.17.2 Vaccines Portfolio
6.17.3 Promising Vaccines in the Clinical Development
6.17.4 Recent Development
6.18 Grifols
6.18.1 Business Overview
6.18.2 Vaccines Portfolio
6.18.3 Recent Development
6.19 Hualan Biological Engineering Inc
6.19.1 Business Overview
6.19.2 Influenza Vaccines Portfolio
6.19.3 Recent Development
6.20 Gamma Vaccines Pty Ltd
6.20.1 Business Overview
6.20.2 Influenza Vaccines Portfolio
6.20.3 Recent Development
LIST OF TABLES:
Table 5–1: Merger & Acquisitions in the Vaccine Market
Table 5–2: Collaboration Deals in the Vaccine Market
Table 5–3: Licensing Agreement in the Vaccine Market
Table 5–4: Exclusive Agreement in the Vaccine Market
Table 5–5: Distribution Agreement in the Vaccine Market
Table 5–6: Partnership Deals in the Vaccine Market
Table 6–1: Sanofi Promising Vaccines in the Clinical Development
Table 6–2: GSK Promising Vaccines in the Clinical Development
Table 6–3: Merck Promising Vaccines in the Clinical Development
Table 6–4: Pfizer Promising Vaccines in the Clinical Development
Table 6–5: Mitsubishi Tanabe Pharma Promising Vaccines in the Clinical Development
Table 6–6: Emergent Biosolutions Promising Vaccines in the Clinical Development
Table 6–7: Valneva Promising Vaccines in the Clinical Development
Table 6–8: Seqirus Promising Vaccines in the Clinical Development
Table 6–9: Bavarian Nordic Promising Vaccines in the Clinical Development
Table 6–10: Sinovac Promising Vaccines in the Clinical Development
Table 6–11: Panacea Biotec Promising Vaccines in the Clinical Development
Table 6–12: Dynavax Technologies Corporation Promising Vaccines in the Clinical Development
Table 6–13: Bharat Biotech Promising Vaccines in the Clinical Development
Table 5–1: Merger & Acquisitions in the Vaccine Market
Table 5–2: Collaboration Deals in the Vaccine Market
Table 5–3: Licensing Agreement in the Vaccine Market
Table 5–4: Exclusive Agreement in the Vaccine Market
Table 5–5: Distribution Agreement in the Vaccine Market
Table 5–6: Partnership Deals in the Vaccine Market
Table 6–1: Sanofi Promising Vaccines in the Clinical Development
Table 6–2: GSK Promising Vaccines in the Clinical Development
Table 6–3: Merck Promising Vaccines in the Clinical Development
Table 6–4: Pfizer Promising Vaccines in the Clinical Development
Table 6–5: Mitsubishi Tanabe Pharma Promising Vaccines in the Clinical Development
Table 6–6: Emergent Biosolutions Promising Vaccines in the Clinical Development
Table 6–7: Valneva Promising Vaccines in the Clinical Development
Table 6–8: Seqirus Promising Vaccines in the Clinical Development
Table 6–9: Bavarian Nordic Promising Vaccines in the Clinical Development
Table 6–10: Sinovac Promising Vaccines in the Clinical Development
Table 6–11: Panacea Biotec Promising Vaccines in the Clinical Development
Table 6–12: Dynavax Technologies Corporation Promising Vaccines in the Clinical Development
Table 6–13: Bharat Biotech Promising Vaccines in the Clinical Development
LIST OF FIGURES:
Figure 2–1: Global Top 20 Vaccine Companies Sales Value (Million US$),2015 – 2019
Figure 3–1: Market Share Analysis of the Top 20 Vaccine Companies (Percent), 2019
Figure 6–1: Sanofi Pasteur Vaccines Market Value Analysis (Million US$),2015 – 2019
Figure 6–2: GSK Vaccines Market Value Analysis (Million US$),2015 – 2019
Figure 6–3: Merck Vaccines Market Value Analysis (Million US$),2015 – 2019
Figure 6–4: Pfizer Vaccines Market Value Analysis (Million US$),2015 – 2019
Figure 6–5: AstraZeneca Vaccines Market Value Analysis (Million US$),2015 – 2018
Figure 6–6: Mitsubishi Tanabe Pharma Vaccines Market Value Analysis (Million US$),2015 – 2018
Figure 6–7: Emergent Biosolutions Vaccines Market Value Analysis (Million US$),2015 – 2019
Figure 6–8: Astlellas Pharma Inc Vaccines Market Value Analysis (Million US$),2015 – 2018
Figure 6–9: Valneva Vaccines Market Value Analysis (Million US$),2015 – 2019
Figure 6–10: Seqirus Vaccines Market Value Analysis (Million US$),2015 - 2019
Figure 6–11: Bavarian Nordic Vaccines Market Value Analysis (Million US$),2015 – 2019
Figure 6–12: Sinovac Vaccines Market Value Analysis (Million US$),2015 – 2019
Figure 6–13: Panacea Biotec Vaccines Market Value Analysis (Million US$),2015 – 2019
Figure 6–14: Dynavax Vaccines Market Value Analysis (Million US$),2018 – 2019
Figure 2–1: Global Top 20 Vaccine Companies Sales Value (Million US$),2015 – 2019
Figure 3–1: Market Share Analysis of the Top 20 Vaccine Companies (Percent), 2019
Figure 6–1: Sanofi Pasteur Vaccines Market Value Analysis (Million US$),2015 – 2019
Figure 6–2: GSK Vaccines Market Value Analysis (Million US$),2015 – 2019
Figure 6–3: Merck Vaccines Market Value Analysis (Million US$),2015 – 2019
Figure 6–4: Pfizer Vaccines Market Value Analysis (Million US$),2015 – 2019
Figure 6–5: AstraZeneca Vaccines Market Value Analysis (Million US$),2015 – 2018
Figure 6–6: Mitsubishi Tanabe Pharma Vaccines Market Value Analysis (Million US$),2015 – 2018
Figure 6–7: Emergent Biosolutions Vaccines Market Value Analysis (Million US$),2015 – 2019
Figure 6–8: Astlellas Pharma Inc Vaccines Market Value Analysis (Million US$),2015 – 2018
Figure 6–9: Valneva Vaccines Market Value Analysis (Million US$),2015 – 2019
Figure 6–10: Seqirus Vaccines Market Value Analysis (Million US$),2015 - 2019
Figure 6–11: Bavarian Nordic Vaccines Market Value Analysis (Million US$),2015 – 2019
Figure 6–12: Sinovac Vaccines Market Value Analysis (Million US$),2015 – 2019
Figure 6–13: Panacea Biotec Vaccines Market Value Analysis (Million US$),2015 – 2019
Figure 6–14: Dynavax Vaccines Market Value Analysis (Million US$),2018 – 2019
